Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 2.21 USD -1.78%
Market Cap: 130.3m USD
Have any thoughts about
Seer Inc?
Write Note

Seer Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seer Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Seer Inc
NASDAQ:SEER
Total Current Assets
$330.5m
CAGR 3-Years
-9%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Total Current Assets
$23.8B
CAGR 3-Years
-1%
CAGR 5-Years
18%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Total Current Assets
$10.1B
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Total Current Assets
$1.2B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
3%
Agilent Technologies Inc
NYSE:A
Total Current Assets
$4B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Total Current Assets
$5.6B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

Seer Inc
Glance View

Market Cap
131.7m USD
Industry
Life Sciences Tools & Services

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
3.19 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Seer Inc's Total Current Assets?
Total Current Assets
330.5m USD

Based on the financial report for Dec 31, 2023, Seer Inc's Total Current Assets amounts to 330.5m USD.

What is Seer Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
60%

Over the last year, the Total Current Assets growth was -24%. The average annual Total Current Assets growth rates for Seer Inc have been -9% over the past three years , 60% over the past five years .

Back to Top